Are Labs Ready for HPV Self-sampling?

• by Helen Bristow

• October 7, 2026

FDA clears targeted cholangiocarcinoma therapy

In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.

• by Kathryn Wighton

• September 24, 2026

• 2 min

Retained silk may underlie late postvasectomy fistula

Surgery and histopathology identified retained silk ligature with chronic inflammation at the site of a rare fistula presenting 3 years following vasectomy.

• by Andrea Surnit

• September 18, 2026

• 4 min

Updated Estimates of Agreement Between Dispensed Medications and Forensic Toxicology in Sweden

• by Heidi Taipale, Jari Tiihonen, Antti Tanskanen, Jonas Forsman

• September 24, 2026